Haverford School lax checks for cancer
Evelyn Schwartz, Director of Development of the Abramson Family Cancer Research Institute at Penn Medicine, accepts a $12,000 donation from the Checking for Cancer Foundation.
Read more on Main Line Times
Haverford School lax checks for cancer
Evelyn Schwartz, Director of Development of the Abramson Family Cancer Research Institute at Penn Medicine, accepts a $12,000 donation from the Checking for Cancer Foundation.
Read more on Main Line Times
Whilst doing some research I came across an interesting acne study carried out by the Johns Hopkins Bloomberg School of Medicine. It proposes that there could be a link between severe acne and prostate cancer in men.
The main reason the study was carried out was to investigate existing research that showed that the Propionibacterium acnes (P.Acnes) bacteria was present in one third of prostate tissue samples taken from men with prostate cancer.
» Read more: Acne Linked to Prostate Cancer?
In this study, a team led by Gosse J. Adema, Ph.D., of the Department of Tumor Immunology, at the Radboud University Nijmegen Medical Centre, the Netherlands, and colleagues assessed the role of DC-SCRIPT as a co-regulator of nuclear receptors, including estrogen receptor (ER), progesterone receptor (PR)-B, peroxisome proliferator-activated receptor gamma, and retinoic acid receptor alpha. Prognostic value was assessed in three independent cohorts of breast cancer patients.
The researchers found that DC-SCRIPT suppressed ER- and PR-mediated transcription in a ligand-dependent fashion, whereas it enhanced the activity of the other two receptors. Quantification of DC-SCRIPT mRNA expression in the three cohorts of patients revealed that this expression is an independent prognostic factor for breast cancer patients with ER- and/or PR-positive tumors, according to the authors.
» Read more: DC-SCRIPT Found to Have Prognostic Value in Breast Cancer